In squamous cell lung carcinoma low cell surface syndecan-1 expression is associated with unfavorable outcome [123] and the majority of NSCLC express varying syndecan-1 reactivity by immunohistochemistry of tumor tissue. Here, SDC1 is linked to non-small cell lung carcinoma.